Niall P Quinn

Niall P Quinn

UNVERIFIED PROFILE

Are you Niall P Quinn?   Register this Author

Register author
Niall P Quinn

Niall P Quinn

Publications by authors named "Niall P Quinn"

Are you Niall P Quinn?   Register this Author

70Publications

1263Reads

35Profile Views

Soft signs in movement disorders: friends or foes?

J Neurol Neurosurg Psychiatry 2019 Aug 8;90(8):961-962. Epub 2018 Nov 8.

Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital - UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-318455
Publisher Site
http://dx.doi.org/10.1136/jnnp-2018-318455DOI Listing
August 2019

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology 2018 01 13;90(2):74-82. Epub 2017 Dec 13.

From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square Brain Bank (J.H.), UCL Institute of Neurology (N.P.Q.), London, UK; UPS, INSERM, and CHU de Toulouse (O.R.), University de Toulouse; Centre de Référence Maladie Rare contre l'AMS (O.R.), Centre d'Investigation Clinique CIC1436, Départments de Pharmacologie Clinique et de Neurosciences, NeuroToul/COEN Center of Excellence in Neurodegeneration, Toulouse, France; Department of Pathology & Laboratory Medicine (L.M.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Manhasset, NY; The Multiple System Atrophy (MSA) Coalition, Inc. (P. B., J.B., P.F., L.K., C.L., C.R., S.S.), Charlotte, NC; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Medical Affairs (V.A.), Teva Pharmaceuticals, Frazer, PA; Department of Neurology (G.B.), David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles; Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK; Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, Grand Rapids, MI; Center for Neurological Restoration (H.F.), Cleveland Clinic, OH; Defeat MSA (P.F.); MSA Shoe Charity (P.F., C.R.), Saint Clair Shores, MI; Department of Neurology (R.F.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurodegenerative Diseases (T.G.), Hertie Institute of Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.), Tübingen, Germany; Lundbeck LLC (A.H.), Deerfield, IL; German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Munich; Department of Neurology (G.U.H.), Technical University of Munich, Germany; Neurogenomics Division (M.J.H.), The Translational Genomics Research Institute, Phoenix, AZ; Dandrite & Department of Biomedicine (P.H.J.), Aarhus University, Denmark; Quanterix (A.J.), Lexington, MA; Department of Neurology (U.J.K.), Columbia University Medical Center; Department of Neurology (H.K.), New York University School of Medicine, New York; Whitehead Institute for Biomedical Research (V.K.), Cambridge; Ann Romney Center for Neurologic Disease (V.K.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard Stem Cell Institute (V.K.), Cambridge, MA; Department of Neurology (T.K.), University of Bonn; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany; Brain and Mind Centre (W.S.K.), Sydney Medical School, University of Sydney, Australia; Department of Neurology (P.L.), Henry Ford Hospital; Department of Neurology (P.L.), Wayne State University School of Medicine, Detroit, MI; Division of Neurosciences (E.M.), National Institute on Aging/NIH, Bethesda, MD; Centre de Référence Maladie Rare AMS (W.M.), Hôpital Pellegrin, CHU de Bordeaux; Université de Bordeaux (W.M.), Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux; Paris Saclay Institute of Neuroscience (R.M.), CNRS, Gif-sur-Yvette, France; Genentech Inc. (S.O.), South San Francisco; Cedars-Sinai Medical Center (S.P.), Los Angeles, CA; Department of Neurology (D.R.), Vanderbilt University Medical Center, Nashville, TN; MSA NJ (C.R.), Howell, NJ; Prothena Biosciences (D.S.), South San Francisco, CA; Division of Neurology (M.S.), Department of Medicine, The Ottawa Hospital, Canada; Department of Neurology (J.D.S.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Cure MSA Foundation (L.S.), Fremont, CA; Avid Radiopharmaceuticals (A.S.), Philadelphia, PA; Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (S.T.), Graduate School of Medicine, Tokyo University, Tokyo, Japan; and University of Washington (J.Z.), Seattle. W.R.G. is currently affiliated with Janssen Research and Development, Titusville, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772155PMC
January 2018

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.

J Neurol Neurosurg Psychiatry 2016 Mar 19;87(3):319-23. Epub 2015 May 19.

Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2014-310256DOI Listing
March 2016

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Qual Life Res 2016 Jan 12;25(1):81-8. Epub 2015 Aug 12.

Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-015-1071-yDOI Listing
January 2016

H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?

Mov Disord 2015 May 27;30(6):828-33. Epub 2014 Dec 27.

Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26129DOI Listing
May 2015

"Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.

Mov Disord 2013 Aug 29;28(9):1184-99. Epub 2013 May 29.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25509DOI Listing
August 2013

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.

Sci Transl Med 2012 Apr;4(128):128ra41

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003391DOI Listing
April 2012

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

Mov Disord 2011 Sep 24;26(11):1997-2003. Epub 2011 May 24.

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23743DOI Listing
September 2011

Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment.

Mov Disord 2011 Aug 5;26(10):1913-21. Epub 2011 May 5.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL-Institute of Neurology, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23731DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174341PMC
August 2011

Tremor--some controversial aspects.

Mov Disord 2011 Jan 10;26(1):18-23. Epub 2010 Dec 10.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23289DOI Listing
January 2011

Nonmotor symptoms in Parkin gene-related parkinsonism.

Mov Disord 2010 Jul;25(9):1279-84

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mds.22897
Publisher Site
http://dx.doi.org/10.1002/mds.22897DOI Listing
July 2010

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Mov Disord 2010 Jun;25(8):979-84

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22947DOI Listing
June 2010

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Sci Transl Med 2010 Jun;2(38):38ra46

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3000976DOI Listing
June 2010

In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.

Exp Neurol 2010 Mar 4;222(1):120-4. Epub 2010 Jan 4.

MRC Clinical Science Centre and Division of Neuroscience and Mental Health, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2009.12.021DOI Listing
March 2010

The clinical approach to movement disorders.

Nat Rev Neurol 2010 Jan;6(1):29-37

Parkinson Centre Nijmegen (ParC), Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2009.196DOI Listing
January 2010

Reckless generosity in Parkinson's disease.

Mov Disord 2010 Jan;25(2):221-3

Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22687DOI Listing
January 2010

Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.

Mov Disord 2009 Nov;24(15):2260-6

MRC Clinical Science Centre, Imperial College, London, United Kingdom. nicola.pavese@ csc.mrc.ac.uk

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22817DOI Listing
November 2009

A validation exercise on the new consensus criteria for multiple system atrophy.

Mov Disord 2009 Nov;24(15):2272-6

National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22826DOI Listing
November 2009

GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias.

Mov Disord 2009 Aug;24(11):1684-8

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22507DOI Listing
August 2009

Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp.

Mov Disord 2008 Oct;23(13):1913-5

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21935DOI Listing
October 2008

Paroxysmal dyskinesia with interictal myoclonus and dystonia: a report of two cases.

Parkinsonism Relat Disord 2008 26;14(3):250-2. Epub 2007 Nov 26.

Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2007.03.005DOI Listing
August 2008

Quality of life in Parkinson's disease: the relative importance of the symptoms.

Mov Disord 2008 Jul;23(10):1428-34

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21667DOI Listing
July 2008

Antineuronal antibodies in Parkinson's disease.

Mov Disord 2008 May;23(7):958-963

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21929DOI Listing
May 2008

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Nat Med 2008 May 6;14(5):501-3. Epub 2008 Apr 6.

Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, 221 84 Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1746DOI Listing
May 2008

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

Mov Disord 2008 Feb;23(3):416-21

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21888DOI Listing
February 2008

The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.

Mov Disord 2008 Jan;23(1):107-13

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21812DOI Listing
January 2008

The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy.

Mov Disord 2007 Dec;22(16):2325-31

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21634DOI Listing
December 2007

Primary lateral sclerosis mimicking atypical parkinsonism.

Mov Disord 2007 Oct;22(14):2057-62

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21645DOI Listing
October 2007

Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene.

Mov Disord 2007 Jul;22(9):1328-31

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mds.21351
Publisher Site
http://dx.doi.org/10.1002/mds.21351DOI Listing
July 2007

Rate of clinical progression in Parkinson's disease. A prospective study.

Mov Disord 2007 May;22(7):938-45

Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21429DOI Listing
May 2007

The entity of young onset primary cervical dystonia.

Mov Disord 2007 Apr;22(6):843-7

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21421DOI Listing
April 2007

NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.

Mov Disord 2006 Nov;21(11):1960-3

Department of Molecular Neuroscience, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21018DOI Listing
November 2006

Atypical movement disorders in antiphospholipid syndrome.

Mov Disord 2006 Jul;21(7):944-9

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20842DOI Listing
July 2006

Adult-onset primary lower limb dystonia.

Mov Disord 2006 Jun;21(6):767-71

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20794DOI Listing
June 2006

Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.

Mov Disord 2006 Jun;21(6):783-8

MRC Clinical Science Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20811DOI Listing
June 2006

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.

Mov Disord 2006 Jan;21(1):89-93

MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, and National Hospital for Neurology and Neurosurgery, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20668DOI Listing
January 2006

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.

Brain 2005 Dec 24;128(Pt 12):2977-86. Epub 2005 Oct 24.

MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awh649DOI Listing
December 2005

How to diagnose multiple system atrophy.

Authors:
Niall P Quinn

Mov Disord 2005 Aug;20 Suppl 12:S5-S10

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20534DOI Listing
August 2005

Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene.

Mov Disord 2005 Feb;20(2):243-5

Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20280DOI Listing
February 2005

A common LRRK2 mutation in idiopathic Parkinson's disease.

Lancet 2005 Jan 29-Feb 4;365(9457):415-6

Department of Molecular Neuroscience, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(05)17830-1DOI Listing
February 2005

Progression of parkinsonism in multiple system atrophy.

J Neurol 2005 Jan;252(1):91-6

Department of Neurology, University Hospital, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-005-0617-2DOI Listing
January 2005

Occupational therapy in multiple system atrophy: a pilot randomized controlled trial.

Mov Disord 2004 Nov;19(11):1360-4

National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20211DOI Listing
November 2004

Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies.

Mov Disord 2004 Oct;19(10):1190-6

Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, University College London, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20126DOI Listing
October 2004

The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism.

Ann Neurol 2004 Sep;56(3):329-35

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20206DOI Listing
September 2004

Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.

Brain 2004 Jun 16;127(Pt 6):1332-42. Epub 2004 Apr 16.

MRC Clinical Science Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awh150DOI Listing
June 2004

Vascular parkinsonism.

J Neurol 2004 May;251(5):513-24

Service de Neurologie, Hopital Haut-Lévèque Groupe Hospitalier Sud, CHU de Bordeaux, Av de Magellan, 33600, Pessac, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-004-0421-4
Publisher Site
http://dx.doi.org/10.1007/s00415-004-0421-4DOI Listing
May 2004

Choreic syndrome and coeliac disease: a hitherto unrecognised association.

Mov Disord 2004 Apr;19(4):478-82

Sobell Dept of Motor Neuroscience and Movement Disorders, Institute of Neurology, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mds.10691
Publisher Site
http://dx.doi.org/10.1002/mds.10691DOI Listing
April 2004

Myoclonus in spinal dysraphism.

Mov Disord 2003 Aug;18(8):961-4

Department of Neurology, Royal Adelaide Hospital, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10469DOI Listing
August 2003

Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type.

Mov Disord 2003 Apr;18(4):430-2

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10384DOI Listing
April 2003

Pallidotomy and incidental sequence learning in Parkinson's disease.

Neuroreport 2003 Jan;14(1):21-4

Department of Psychology, PO77, Institute of Psychiatry, King's College, De Crespigny Park, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001756-200301200-00004DOI Listing
January 2003

Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.

Mov Disord 2002 Jul;17(4):701-9

Fédération de Neurologie, Epidémiologie et Biostatistiques Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10171DOI Listing
July 2002

Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses?

Eur Neurol 2002 ;47(2):118-21

Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000047963DOI Listing
April 2002